The team from Telos Partners is back from another successful meeting at AAOS 2018. We met with a number of new prospective clients, as well as visited and caught up with current clients and old friends in the industry. The annual meeting of the American Academy of Orthopedic Surgeons (AAOS) is the largest gathering of orthopedic surgeons and manufacturers […]
Telos Partners will be hosting a series of strategic discussions during AAOS for several of its musculoskeletal clients, as well as others wishing to explore opportunities to accelerate commercialization objectives. Meeting requests can be sent to firstname.lastname@example.org. We look forward to seeing you in New Orleans!
DENVER, December 12, 2017 (Newswire.com) – Global life sciences group Telos Partners LLC (telospartnersllc.com) is pleased to announce the appointment of Jason Inzana, Ph.D., as manager of Evidence Strategy and Development. In this role, Dr. Inzana will facilitate the ongoing growth of the Telos Partners brand and support the company’s mission of threading the needle between scientific, regulatory and publication objectives to accomplish client goals.
Telos Partners recently attended NASS 2017 in Orlando, Florida. They participated in a number of meetings with companies looking to explore opportunities to improve efforts towards evidence generation and the development of quality publications / presentations in concert with their commercialization strategy.
Telos Partners founder Joel Batts recently moderated an expert panel discussion with Jeff Muir from Intellijoint and Katie Kleinschuster from Aesculap Implant Systems at JLABS in Toronto, Canada. Healthcare leaders from both start-ups and well-established organizations learned how they can leverage the benefits of developing and executing a long-term publication strategy, while recognizing clinical evidence […]
Telos Partners, LLC, a firm providing scientific, regulatory and publication services to the life sciences industry, has been selected by Acera Surgical to lead its Restrata™ wound matrix study titled: “Clinical Outcomes after Treatment with Restrata™ in Diabetic Foot Ulcers (DFU): A Case Series of Initial Effectiveness and Safety Measures.” The clinical trial is a […]